{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:58:12Z","timestamp":1781639892594,"version":"3.54.5"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100019721","name":"Roche Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019721","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04108-5","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T23:48:56Z","timestamp":1741132136000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prevalence and incidence of multiple sclerosis in healthcare district IV of Asturias, Spain"],"prefix":"10.1186","volume":"25","author":[{"given":"Pedro","family":"Oliva-Nacarino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Simal Antu\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Santos Varela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Villafani Echaz\u00fa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Fern\u00e1ndez Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Garc\u00eda Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agust\u00edn","family":"Oterino Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Suarez Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"Llaneza Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"4108_CR1","doi-asserted-by":"crossref","unstructured":"Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler. 2020 ;26(14):1816\u201321.","DOI":"10.1177\/1352458520970841"},{"issue":"11","key":"4108_CR2","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41582-021-00556-y","volume":"17","author":"N Koch-Henriksen","year":"2021","unstructured":"Koch-Henriksen N, Magyari M. Apparent changes in the epidemiology and severity of multiple sclerosis. Nat Rev Neurol. 2021;17(11):676\u201388.","journal-title":"Nat Rev Neurol"},{"key":"4108_CR3","unstructured":"Number of people with MS | Atlas of MS. Available from: https:\/\/www.atlasofms.org\/map\/global\/epidemiology\/number-of-people-with-ms. Cited 2022 Mar 13."},{"issue":"10","key":"4108_CR4","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1177\/1352458514561904","volume":"21","author":"C Solaro","year":"2015","unstructured":"Solaro C, Ponzio M, Moran E, Tanganelli P, Pizio R, Ribizzi G, et al. The changing face of multiple sclerosis: Prevalence and incidence in an aging population. Mult Scler. 2015;21(10):1244\u201350.","journal-title":"Mult Scler"},{"issue":"3","key":"4108_CR5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/jnnp-2019-322348","volume":"91","author":"L Prosperini","year":"2020","unstructured":"Prosperini L, Mancinelli C, Haggiag S, Cordioli C, De Giglio L, De Rossi N, et al. Minimal evidence of disease activity (MEDA) in relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry. 2020;91(3):271\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"4108_CR6","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3390\/jcm9051326","volume":"9","author":"O Mirmosayyeb","year":"2020","unstructured":"Mirmosayyeb O, Brand S, Barzegar M, Afshari-Safavi A, Nehzat N, Shaygannejad V, et al. Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis. J Clin Med. 2020;9(5):1326.","journal-title":"J Clin Med"},{"key":"4108_CR7","doi-asserted-by":"crossref","first-page":"104506","DOI":"10.1016\/j.msard.2023.104506","volume":"70","author":"J Moura","year":"2023","unstructured":"Moura J, Duarte S, Oliveira V, Pereira D, Costa D, Sam\u00f5es R, et al. Characterization of a late-onset multiple sclerosis Portuguese cohort. Mult Scler Relat Disord. 2023Feb;70: 104506.","journal-title":"Mult Scler Relat Disord"},{"key":"4108_CR8","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102816","volume":"50","author":"A Naseri","year":"2021","unstructured":"Naseri A, Nasiri E, Sahraian MA, Daneshvar S, Talebi M. Clinical Features of Late-Onset Multiple Sclerosis: a Systematic Review and Meta-analysis. Mult Scler Relat Disord. 2021;50: 102816.","journal-title":"Mult Scler Relat Disord"},{"key":"4108_CR9","unstructured":"Garc\u00eda L\u00f3pez FJ, Garc\u00eda-Merino A, Alcalde-Cabero E, De Pedro-Cuesta J. Incidence and prevalence of multiple sclerosis in Spain: a systematic review. Neurolog\u00eda (English Edition). 2022;S2173580822001778."},{"key":"4108_CR10","unstructured":"INE. Asturias: Poblaci\u00f3n por municipios y sexo. (2886). Available from: https:\/\/www.ine.es\/jaxiT3\/Tabla.htm?t=2886&L=0. Cited 2022 Apr 9."},{"key":"4108_CR11","unstructured":"Demograf\u00eda - IDEPA. Available from: https:\/\/www.idepa.es\/conocimiento\/asturias-en-cifras\/demografia. Cited 2024 Jan 16."},{"issue":"2","key":"4108_CR12","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. The Lancet Neurology. 2018;17(2):162\u201373.","journal-title":"Lancet Neurology"},{"issue":"3","key":"4108_CR13","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","volume":"83","author":"FD Lublin","year":"2014","unstructured":"Lublin FD, Reingold SC, Cohen JA, Cutter GR, S\u00f8rensen PS, Thompson AJ, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014;83(3):278\u201386.","journal-title":"Neurology"},{"key":"4108_CR14","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1201\/b16654","volume-title":"Modelling Binary Data","author":"D Collett","year":"2002","unstructured":"Collett D. Modelling Binary Data. 2nd ed. New York: Chapman and Hall\/CRC; 2002. p. 408.","edition":"2"},{"key":"4108_CR15","unstructured":"Stevenson M, Sergeant E, Heuer C, Nunes T, Heuer C, Marshall J, et al. epiR: Tools for the Analysis of Epidemiological Data. 2024. Available from: https:\/\/cran.r-project.org\/web\/packages\/epiR\/index.html. Cited 2025 Jan 23."},{"issue":"11","key":"4108_CR16","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444\u201352.","journal-title":"Neurology"},{"issue":"6","key":"4108_CR17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1600-0404.1997.tb00301.x","volume":"96","author":"DF Uria","year":"1997","unstructured":"Uria DF, Abad P, Calatayud MT, Virgala P, Diaz A, Chamizo C, et al. Multiple sclerosis in Gijon health district, Asturias, northern Spain. Acta Neurol Scand. 1997;96(6):375\u20139.","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"4108_CR18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev-publhealth-032315-021353","volume":"37","author":"JA Casey","year":"2016","unstructured":"Casey JA, Schwartz BS, Stewart WF, Adler NE. Using Electronic Health Records for Population Health Research: A Review of Methods and Applications. Annu Rev Public Health. 2016;37(1):61\u201381.","journal-title":"Annu Rev Public Health"},{"issue":"3","key":"4108_CR19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/ane.13265","volume":"142","author":"E Costa Arp\u00edn","year":"2020","unstructured":"Costa Arp\u00edn E, Naveiro Soneira J, Lema Bouzas M, Gonz\u00e1lez Quintela A, Prieto Gonz\u00e1lez JM. Epidemiology of multiple sclerosis in Santiago de Compostela (Spain). Acta Neurol Scand. 2020;142(3):267\u201374.","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"4108_CR20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.33588\/rn.7101.2019432","volume":"71","author":"DA Garc\u00eda-Est\u00e9vez","year":"2020","unstructured":"Garc\u00eda-Est\u00e9vez DA, Fraga-Gonz\u00e1lez C, Ramos-Pacho ME, L\u00f3pez-D\u00edaz LM, Pardo-Parrado M, Prieto JM. The prevalence of multiple sclerosis in the city of Ourense, Galicia, in the north-west of the Iberian Peninsula. Rev Neurol. 2020;71(1):19\u201325.","journal-title":"Rev Neurol"},{"key":"4108_CR21","unstructured":"Llaneza Gonz\u00e1lez M\u00c1. Epidemiolog\u00eda de la Esclerosis M\u00faltiple en el \u00e1rea sanitaria de Ferrol. 2016. Available from: http:\/\/hdl.handle.net\/2183\/17565. Cited 2022 Apr 9."},{"issue":"5","key":"4108_CR22","first-page":"1058","volume":"38","author":"A D\u00edaz-L\u00f3pez","year":"2021","unstructured":"D\u00edaz-L\u00f3pez A, Paz-Graniel I, Alonso-Sanz R, Marqu\u00e9s Baldero C, Mateos Gil C, Arija VV. Vitamin D deficiency in primary health care users at risk in Spain. Nutr Hosp. 2021;38(5):1058\u201367.","journal-title":"Nutr Hosp"},{"issue":"11","key":"4108_CR23","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1136\/jnnp-2018-320189","volume":"90","author":"S Simpson","year":"2019","unstructured":"Simpson S, Wang W, Otahal P, Blizzard L, Van Der Mei IAF, Taylor BV. Latitude continues to be significantly associated with the prevalence of multiple sclerosis: an updated meta-analysis. J Neurol Neurosurg Psychiatry. 2019;90(11):1193\u2013200.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4108_CR24","doi-asserted-by":"publisher","unstructured":"Hwang S, Garcia-Dominguez MA, Fitzgerald KC, Saylor DR. Association of Multiple Sclerosis Prevalence With Sociodemographic, Health Systems, and Lifestyle Factors on a National and Regional Level. Neurology. 2022. https:\/\/doi.org\/10.1212\/WNL.0000000000200962.","DOI":"10.1212\/WNL.0000000000200962"},{"issue":"7","key":"4108_CR25","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1093\/brain\/awab104","volume":"144","author":"CE Sabel","year":"2021","unstructured":"Sabel CE, Pearson JF, Mason DF, Willoughby E, Abernethy DA, Taylor BV. The latitude gradient for multiple sclerosis prevalence is established in the early life course. Brain. 2021;144(7):2038\u201346.","journal-title":"Brain"},{"issue":"3","key":"4108_CR26","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/1352458512451942","volume":"19","author":"G Disanto","year":"2013","unstructured":"Disanto G, Pakpoor J, Morahan JM, Hall C, Meier UC, Giovannoni G, et al. Epstein-Barr virus, latitude and multiple sclerosis. Mult Scler. 2013;19(3):362\u20135.","journal-title":"Mult Scler"},{"issue":"6","key":"4108_CR27","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1177\/1352458513505693","volume":"20","author":"A Lossius","year":"2014","unstructured":"Lossius A, Riise T, Pugliatti M, Bj\u00f8rnevik K, Casetta I, Drulovic J, et al. Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; the EnvIMS Study. Mult Scler. 2014;20(6):669\u201374.","journal-title":"Mult Scler"},{"issue":"9","key":"4108_CR28","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/j.1468-1331.2010.03003.x","volume":"17","author":"AE Handel","year":"2010","unstructured":"Handel AE, Handunnetthi L, Giovannoni G, Ebers GC, Ramagopalan SV. Genetic and environmental factors and the distribution of multiple sclerosis in Europe. Eur J Neurol. 2010;17(9):1210\u20134.","journal-title":"Eur J Neurol"},{"issue":"4","key":"4108_CR29","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/jnnp.2003.012666","volume":"75","author":"C McGuigan","year":"2004","unstructured":"McGuigan C, McCarthy A, Quigley C, Bannan L, Hawkins SA, Hutchinson M. Latitudinal variation in the prevalence of multiple sclerosis in Ireland, an effect of genetic diversity. J Neurol Neurosurg Psychiatry. 2004;75(4):572\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"4108_CR30","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1136\/jnnp.2010.220988","volume":"82","author":"R Lonergan","year":"2011","unstructured":"Lonergan R, Kinsella K, Fitzpatrick P, Brady J, Murray B, Dunne C, et al. Multiple sclerosis prevalence in Ireland: relationship to vitamin D status and HLA genotype. J Neurol Neurosurg Psychiatry. 2011;82(3):317\u201322.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"4108_CR31","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1399-0039.2008.01066.x","volume":"72","author":"JL Fernandez-Morera","year":"2008","unstructured":"Fernandez-Morera JL, Rodriguez-Rodero S, Tunon A, Martinez-Borra J, Vidal-Castineira JR, Lopez-Vazquez A, et al. Genetic influence of the nonclassical major histocompatibility complex class I molecule MICB in multiple sclerosis susceptibility. Tissue Antigens. 2008;72(1):54\u20139.","journal-title":"Tissue Antigens"},{"issue":"11","key":"4108_CR32","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1212\/WNL.0000000000002469","volume":"86","author":"P Dilokthornsakul","year":"2016","unstructured":"Dilokthornsakul P, Valuck RJ, Nair KV, Corboy JR, Allen RR, Campbell JD. Multiple sclerosis prevalence in the United States commercially insured population. Neurology. 2016;86(11):1014\u201321.","journal-title":"Neurology"},{"issue":"13","key":"4108_CR33","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2377-13-128","volume":"26","author":"E Kingwell","year":"2013","unstructured":"Kingwell E, Marriott JJ, Jett\u00e9 N, Pringsheim T, Makhani N, Morrow SA, et al. Incidence and prevalence of multiple sclerosis in Europe: a systematic review. BMC Neurol. 2013;26(13):128.","journal-title":"BMC Neurol"},{"issue":"5","key":"4108_CR34","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S1474-4422(10)70064-8","volume":"9","author":"N Koch-Henriksen","year":"2010","unstructured":"Koch-Henriksen N, S\u00f8rensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 2010;9(5):520\u201332.","journal-title":"Lancet Neurol"},{"key":"4108_CR35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.msard.2019.05.022","volume":"33","author":"N Perez-Carmona","year":"2019","unstructured":"Perez-Carmona N, Gimenez-Martinez J, Borrego-Honrubia C, Sempere AP. Multiple sclerosis prevalence and incidence in San Vicente del Raspeig. Spain Mult Scler Relat Disord. 2019;33:78\u201381.","journal-title":"Spain Mult Scler Relat Disord"},{"issue":"09","key":"4108_CR36","doi-asserted-by":"crossref","first-page":"396","DOI":"10.33588\/rn.6209.2015344","volume":"62","author":"E Carre\u00f3n Guarnizo","year":"2016","unstructured":"Carre\u00f3n Guarnizo E, Andr\u00e9u Rein\u00f3n E, Cerd\u00e1n S\u00e1nchez M, Carrasco Torres R, Hern\u00e1ndez Clares R, Prieto Valiente L, et al. Prevalencia de la esclerosis m\u00faltiple en la Regi\u00f3n de Murcia. RevNeurol. 2016;62(09):396.","journal-title":"RevNeurol"},{"key":"4108_CR37","doi-asserted-by":"crossref","first-page":"e8235","DOI":"10.7717\/peerj.8235","volume":"7","author":"S P\u00e9rez-P\u00e9rez","year":"2019","unstructured":"P\u00e9rez-P\u00e9rez S, Eguia Del Rio P, Dom\u00ednguez-Mozo MI, Garc\u00eda-Mart\u00ednez M\u00c1, Zapata-Ramos MF, Torrejon MJ, et al. Epidemiology of multiple sclerosis and vitamin D levels in Lanzarote, Canary Islands. Spain PeerJ. 2019;7: e8235.","journal-title":"Spain PeerJ"},{"issue":"01","key":"4108_CR38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.33588\/rn.6901.2018477","volume":"69","author":"N P\u00e9rez Carmona","year":"2019","unstructured":"P\u00e9rez Carmona N, Fern\u00e1ndez Jover E, P\u00e9rez S\u00c1. Epidemiolog\u00eda de la esclerosis m\u00faltiple en Espa\u00f1a. RevNeurol. 2019;69(01):32.","journal-title":"RevNeurol"},{"issue":"1","key":"4108_CR39","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41467-018-08272-w","volume":"10","author":"C Bycroft","year":"2019","unstructured":"Bycroft C, Fernandez-Rozadilla C, Ruiz-Ponte C, Quintela I, Carracedo \u00c1, Donnelly P, et al. Patterns of genetic differentiation and the footprints of historical migrations in the Iberian Peninsula. Nat Commun. 2019;10(1):551.","journal-title":"Nat Commun"},{"key":"4108_CR40","unstructured":"Gonz\u00e1lez M\u00c1L. Epidemiolog\u00eda de la Esclerosis M\u00faltiple en el \u00e1rea sanitaria de Ferrol."},{"key":"4108_CR41","doi-asserted-by":"crossref","first-page":"102909","DOI":"10.1016\/j.msard.2021.102909","volume":"51","author":"S Hashtarkhani","year":"2021","unstructured":"Hashtarkhani S, Tabatabaei-Jafari H, Kiani B, Furst M, Salvador-Carulla L, Bagheri N. Use of geographical information systems in multiple sclerosis research: A systematic scoping review. Multiple Sclerosis and Related Disorders. 2021;51: 102909.","journal-title":"Multiple Sclerosis and Related Disorders"},{"key":"4108_CR42","doi-asserted-by":"crossref","first-page":"102352","DOI":"10.1016\/j.msard.2020.102352","volume":"45","author":"H\u00d8 Flemmen","year":"2020","unstructured":"Flemmen H\u00d8, Simonsen CS, Berg-Hansen P, Moen SM, Kersten H, Heldal K, et al. Prevalence of multiple sclerosis in rural and urban districts in Telemark county. Norway Mult Scler Relat Disord. 2020Oct;45: 102352.","journal-title":"Norway Mult Scler Relat Disord"},{"key":"4108_CR43","doi-asserted-by":"crossref","first-page":"104103","DOI":"10.1016\/j.msard.2022.104103","volume":"68","author":"L Romero-Pinel","year":"2022","unstructured":"Romero-Pinel L, Bau L, Matas E, Le\u00f3n I, Mu\u00f1oz-Vendrell A, Arroyo P, et al. The age at onset of relapsing-remitting multiple sclerosis has increased over the last five decades. Mult Scler Relat Disord. 2022;68: 104103.","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"4108_CR44","first-page":"205521732311985","volume":"9","author":"H Tumani","year":"2023","unstructured":"Tumani H, Coyle PK, C\u00e1rcamo C, Cordioli C, L\u00f3pez PA, Peterka M, et al. Treatment of older patients with multiple sclerosis: Results of an International Delphi Survey. Mult Scler J Exp Transl Clin. 2023Sep 13;9(3):20552173231198588.","journal-title":"Mult Scler J Exp Transl Clin"},{"issue":"14","key":"4108_CR45","doi-asserted-by":"crossref","first-page":"1197212","DOI":"10.3389\/fneur.2023.1197212","volume":"7","author":"G Macaron","year":"2023","unstructured":"Macaron G, Larochelle C, Arbour N, Galmard M, Girard JM, Prat A, et al. Impact of aging on treatment considerations for multiple sclerosis patients. Front Neurol. 2023Jul;7(14):1197212.","journal-title":"Front Neurol"},{"issue":"5","key":"4108_CR46","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jval.2018.03.002","volume":"21","author":"S Auvin","year":"2018","unstructured":"Auvin S, Irwin J, Abi-Aad P, Battersby A. The Problem of Rarity: Estimation of Prevalence in Rare Disease. Value Health. 2018;21(5):501\u20137.","journal-title":"Value Health"},{"issue":"5","key":"4108_CR47","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s10072-019-04205-7","volume":"41","author":"R Bergamaschi","year":"2020","unstructured":"Bergamaschi R, Monti MC, Trivelli L, Introcaso VP, Mallucci G, Borrelli P, et al. Increased prevalence of multiple sclerosis and clusters of different disease risk in Northern Italy. Neurol Sci. 2020;41(5):1089\u201395.","journal-title":"Neurol Sci"},{"issue":"1\u20132","key":"4108_CR48","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jns.2006.01.013","volume":"244","author":"R Bergamaschi","year":"2006","unstructured":"Bergamaschi R, Montomoli C, Candeloro E, Monti MC, Cioccale R, Bernardinelli L, et al. Bayesian mapping of multiple sclerosis prevalence in the province of Pavia, northern Italy. J Neurol Sci. 2006;244(1\u20132):127\u201331.","journal-title":"J Neurol Sci"}],"updated-by":[{"DOI":"10.1186\/s12883-025-04141-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000}}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04108-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04108-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04108-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:33:53Z","timestamp":1742603633000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04108-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4108"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04108-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5409942\/v1","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"assertion":[{"value":"7 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: Part of the legend of Figure 3 is placed in the text of the discussion section. This is now corrected.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2025","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12883-025-04141-4","URL":"https:\/\/doi.org\/10.1186\/s12883-025-04141-4","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study complied with personal data protection laws and human research guidelines and was approved by the ethics committee of our institution, the Ethics and Research Committee of the Principality of Asturias, with the code CEImPA 2023.120. Our dataset is not publicly available. To carry out our project, we requested and obtained a waiver of informed consent due to the nature of the study, which was explicitly approved by the ethics committee. This waiver specifically included the renunciation of the requirement for participants to sign informed consent forms. The committee recommended restricting access to the data, as there may be sensitive information that could compromise the anonymity of the participants. If the editorial committee or readers of our work wish to have direct access to the dataset, we recommend that they contact the Ethics and Research Committee of the Principality of Asturias (ceim.asturias@asturias.org). Our institution\u2019s committee will attend to any requests in this regard, in accordance with local ethical policies and procedures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. The Ethics and Research Committee of the Principality of Asturias has waived the requirement for informed consent for publication based on the use of anonymized data that does not compromise participant privacy.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Pedro Oliva-Nacarino has received lecture honoraria and consultancy fees from Almirall, Biogen Idec, Bristol Myers, Merck, Novartis, Roche, Sanofi, and Teva.Marina Simal Antu\u00f1a has no conflicts of interest.Carmen Santos Varela has no conflicts of interest.Javier Villafani Echaz\u00fa has received lecture honoraria and consultancy fees from Almirall, Biogen Idec, Bristol Myers, Merck, Novartis, Roche, Sanofi, and Teva.Jessica Fern\u00e1ndez Dom\u00ednguez has received lecture honoraria from Biogen Idec, Merck, and Sanofi.Raquel Garc\u00eda Rodr\u00edguez has received lecture honoraria from Biogen, Idec, and Sanofi.Agust\u00edn Oterino Dur\u00e1n has received consultancy fees from Novartis, Sanofi, Merck, and Allergan, and has received research grants from Merck, Novartis, and Bristol.Patricia Suarez Santos has no conflicts of interest.Miguel \u00c1ngel Llaneza Gonz\u00e1lez has received lecture honoraria and consultancy fees from Almirall, Bayer, Biogen Idec, Bristol Myers, Janssen, Merck, Novartis, Roche, Sanofi, Teva, and Viatris.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"85"}}